Literature DB >> 203383

Metabolism and intracellular retention of 1-beta-D-arabinofuranosylcytosine as predictors of response of animal tumors.

Y M Rustum.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 203383

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  7 in total

1.  Synthesis and tumour-localizing properties of [18F]-5-fluorocytosine-arabinoside and [18F]-5-fluorocyclocytidine.

Authors:  G W Visser; O Zwaagstra; G C Gorree; P Moonen; J D Herscheid; A Hoekstra
Journal:  Eur J Nucl Med       Date:  1986

Review 2.  Selective uptake and retention of anticancer agents by sensitive cells.

Authors:  D L Hill; J A Montgomery
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

3.  A simplified assay for measurement of cytosine arabinoside incorporation into DNA in Ara-C-sensitive and -resistant leukemic cells.

Authors:  L P Colly; D J Richel; W Arentsen-Honders; I W Starrenburg; P M Edelbroek; R Willemze
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

4.  Synergistic interaction between 1-beta-D-arabinofuranosylcytosine, thymidine, and hydroxyurea against human B cells and leukemic blasts in vitro.

Authors:  J A Streifel; S B Howell
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

5.  Abrogation of the prognostic significance of low leukemic cell retention of cytosine arabinoside triphosphate by intensification of therapy and by alteration in the dose and schedule of administration of cytosine arabinoside.

Authors:  H D Preisler; Y M Rustum; N Azarnia; R Priore
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

6.  The soft agar clonogenicity and characterization of cells obtained from human solid tumors by mechanical and enzymatic means.

Authors:  H K Slocum; Z P Pavelic; P M Kanter; N J Nowak; Y M Rustum
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

7.  The pharmacologic basis for the efficacy of high-dose Ara-C and sequential asparaginase in adult acute myelogenous leukemia.

Authors:  R L Capizzi; C White
Journal:  Yale J Biol Med       Date:  1988 Jan-Feb
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.